课题基金 / 基金详情

Immune mechanisms of acute respiratory distress syndrome

Immune mechanisms of acute respiratory distress syndrome
急性呼吸窘迫综合征的免疫机制
批准号:
10406858
负责人:
Brian Robert Rosborough
金额:
$4.66万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-05-01 至 2021-12-31
关键词:
AcidosisAcute Lung InjuryAdult Respiratory Distress SyndromeAlveolarAlveolar MacrophagesApplications GrantsBiological MarkersCD14 geneCellsCellular Indexing of Transcriptomes and Epitopes by SequencingClinicalClinical TrialsCritical CareDataDevelopmentDiseaseEdemaEndotheliumEnvironmentEpithelialEpitopesExposure toFCGR3B geneFeedbackFellowshipFlow CytometryFrequenciesFutureGenesGoalsGrantHumanHypersensitivityHypoxemiaImmuneImmunologyInflammationInflammatoryInflammatory ResponseInjuryIntensive Care UnitsInterferon Type IIKidney FailureLeadershipLungMaintenanceMedicineMentorsMessenger RNAMicroarray AnalysisMolecularMorbidity - disease rateNK Cell ActivationNatural Killer CellsPathogenesisPathogenicityPathway interactionsPatient-Focused OutcomesPatientsPeripheral Blood Mononuclear CellPhenotypePhysiciansPneumoniaPositioning AttributeProductionPublicationsRefractoryRegulationResearchResistanceRespiratory FailureRisk FactorsRoleSamplingScientistSepsisSerumShockSignal PathwaySurfaceSurvivorsSyndromeSystemTIS11 proteinTechniquesTechnologyTestingTrainingTraumaUniversitiesWritingbasecareercareer developmentchemokineclinical heterogeneitycognitive disabilitycytokineexperimental studyindexingmonocytemortalitymultidisciplinaryneutrophilnew therapeutic targetnon cardiogenic pulmonary edemanovelpotential biomarkerprotein expressionpsychiatric disabilityrecruitresponsible research conductsingle-cell RNA sequencingskillssurfactanttargeted biomarkertherapeutic targettranscriptometranscriptome sequencingtranscriptomicstranslational study

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT The acute respiratory distress syndrome (ARDS) is a common cause of respiratory failure in the intensive care unit due to overwhelming inflammation in the lung without effective disease modifying treatments. Two sub- phenotypes of ARDS have been identified based on clinical parameters and biomarkers. Compared to hypo- inflammatory ARDS, hyper-inflammatory ARDS is characterized by shock, acidosis, and elevated inflammatory biomarkers. Patients with hyper-inflammatory ARDS have a higher mortality and may respond differentially to treatment. The overarching goal of this training grant proposal is to utilize cutting edge immunology techniques to dissect the immune mechanisms underlying ARDS development and the differentiation between the two sub-phenotypes. In our preliminary data, we identified reduced expression of tristetraprolin (TTP), a negative regulator of cytokine production, in natural killer (NK) cells of patients with ARDS. In Aim 1, we will investigate the mechanisms by which TTP regulates NK cell activation. Additionally, we will use PrimeFlow, a novel flow cytometry-based mRNA quantification technique, to determine if NK cells from patients with ARDS are refractory to negative feedback by inflammatory cytokines due to reduced TTP expression. In Aim 2, we will focus on discovery of immune mechanisms that differentiate hyper- and hypo-inflammatory ARDS. We have found increased frequency of circulating inflammatory non-classical CD14-CD16+ monocytes in hyper- inflammatory ARDS when compared to hypo-inflammatory ARDS patients. We propose using cellular indexing of transcriptomes and epitopes with sequencing (CITE-seq) to investigate signaling pathways at the single cell level in monocytes that differentiate hyper- and hypo-inflammatory ARDS. CITE-seq references single cell RNA sequencing transcriptomic data to surface expression of proteins thereby correlating the transcriptome with flow cytometric surface phenotypes. Together, aims 1 and 2 will test our overall hypotheses that NK cells in ARDS patients are resistant to negative feedback due to reduced TTP expression, and persistent activation of CD16+ non-classical monocytes determines the hyper-inflammatory phenotype of ARDS. Further delineation of immune mechanisms in the development and maintenance of ARDS will advance our understanding of its pathogenesis and identify potential therapeutic targets to modify the disease course of ARDS. The research proposed within this training fellowship will be undertaken at the University of Pittsburgh through a collaborative training environment between the Division of Pulmonary, Allergy and Critical Care Medicine and Department of Immunology to develop research skills in translational human and computational systems immunology. Formal training in the responsible conduct of research and scientific rigor are included in this training proposal, and career development through presentation of research, publication and a multi-disciplinary mentoring committee are aimed at continued progress towards developing an independent physician-scientist career.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金